With many sufferers unaware they’ve dry mouth, privately held Ok Prescription drugs has launched the “first ever” in-office Personalised Xerostomia Protocol (PXP) software to help dentists in figuring out and managing the situation.
Quite than providing a one-size-fits-all resolution, the PXP is designed to be used with each affected person at each appointment. It offers clear tips and an easy-to-follow methodology to establish and educate sufferers on dry mouth signs. Crucially, the PXP additionally facilitates re-evaluating remedy based mostly on sufferers’ evolving well being wants.
‘Silent pandemic’
“Satirically, many people affected by dry mouth stay unaware of their situation,” stated Melissa Turner, BASDH, RDHEP, EFDA, a number one registered dental hygienist and dental model strategist. “Xerostomia has turn into a silent pandemic that may be detrimental to our sufferers’ systemic well being, typically diminishing their high quality of life.”
The PXP software was developed in partnership with Turner, who emphasised its position in heightening consciousness amongst dental professionals and sufferers. “The PXP seeks to propel the dialog ahead and allow us to face collectively for xerostomia aid,” she added.
Rise in dry mouth circumstances
The protocol’s launch comes amid a documented rise in dry mouth circumstances, a situation as soon as primarily related to the aged or disease-related xerostomia. In line with the Faculty of Dental Hygienists of Ontario, prevalence is at the least 20 per cent within the basic inhabitants, with elevated prevalence in females (as much as 30 per cent) and the aged (as much as 50 per cent). In the USA, xerostomia impacts an estimated 30 per cent of sufferers older than 65 years and as much as 40 per cent of sufferers older than 80 years, in response to the American Dental Affiliation. Moreover, the rise can also be on account of negative effects of most drugs together with trending weight reduction medication, use of CPAP machines, and the rising use of marijuana.
What impressed the brand new PXP?
The discharge of the PXP follows the 2023 launch of Ok Prescription drugs’ flagship product, Aquoral Protecting Oral Spray for Dry Mouth Reduction. Aquoral, a patented lipid-based formulation, creates a protecting barrier on the oral mucosa that continues to be intact after consuming or ingesting, making it an efficient complement to present xerostomia therapies.
“Many have described Aquoral as a transformative product, which impressed the event of our new PXP,” stated Bennett Blakeman, CEO of Ok Prescription drugs. “Our mission is to make sure communities not need to undergo from this preventable situation or its typically detrimental systemic results.”